A detailed history of Banque Transatlantique Sa transactions in Organon & Co. stock. As of the latest transaction made, Banque Transatlantique Sa holds 111 shares of OGN stock, worth $835. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Previous 115 3.48%
Holding current value
$835
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$8.4 - $10.85 $33 - $43
-4 Reduced 3.48%
111 $1,000
Q2 2025

Aug 14, 2025

SELL
$8.04 - $14.72 $351,106 - $642,822
-43,670 Reduced 99.74%
115 $1,000
Q1 2025

May 15, 2025

BUY
$14.29 - $16.41 $623,758 - $716,296
43,650 Added 32333.33%
43,785 $651,000
Q4 2024

Feb 14, 2025

BUY
$14.44 - $18.83 $1,949 - $2,542
135 New
135 $2.01 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.